ATE30585T1 - Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen. - Google Patents

Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.

Info

Publication number: ATE30585T1
Authority: AT; Austria
Prior art keywords: treatment; diabetic complications; spirosuccinimide; application; disclosed
Prior art date: 1983-09-23

Application number

AT84306332T

Other languages

English (en)

Inventor

Christopher Andrew Lipinski

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-09-23

Filing date

1984-09-17

Publication date

1987-11-15

1984-09-17 Application filed by Pfizer filed Critical Pfizer

1987-11-15 Application granted granted Critical

1987-11-15 Publication of ATE30585T1 publication Critical patent/ATE30585T1/de

Links

208000002249 Diabetes Complications Diseases 0.000 title abstract 2
206010012655 Diabetic complications Diseases 0.000 title abstract 2
239000003288 aldose reductase inhibitor Substances 0.000 abstract 1
229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003413 spiro compounds Chemical class 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Indole Compounds (AREA)

AT84306332T 1983-09-23 1984-09-17 Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen. ATE30585T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53544483A	1983-09-23	1983-09-23
EP84306332A EP0136143B1 (de)	1983-09-23	1984-09-17	Spirosuccinimide und ihre Anwendung in der Behandlung von Zuckerkrankheitskomplikationen

Publications (1)

Publication Number	Publication Date
ATE30585T1 true ATE30585T1 (de)	1987-11-15

Family

ID=24134256

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT84306332T ATE30585T1 (de)	1983-09-23	1984-09-17	Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.

Country Status (6)

Country	Link
EP (1)	EP0136143B1 (de)
JP (1)	JPS6092264A (de)
AT (1)	ATE30585T1 (de)
DE (1)	DE3467166D1 (de)
DK (1)	DK451184A (de)
GR (1)	GR80428B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3670570D1 (de) *	1986-09-02	1990-05-31	Alcon Lab Inc	Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.
US4946858A (en) *	1988-10-20	1990-08-07	American Home Products Corporation	Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US4900739A (en) *	1988-10-20	1990-02-13	American Home Products Corp.	Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US5039672A (en) *	1990-04-05	1991-08-13	Pfizer Inc.	Heterocyclic compounds as aldose reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3985888A (en) *	1969-07-24	1976-10-12	Richardson-Merrell Inc.	Methods of inducing sedation using certain spiroalkanone-imides
US4117230A (en) *	1976-10-18	1978-09-26	Pfizer Inc.	Hydantoin derivatives as therapeutic agents
US4307108A (en) *	1979-12-26	1981-12-22	Pfizer Inc.	Method for lowering sorbitol levels using spiro-imides
EP0065392B1 (de) *	1981-05-13	1985-02-13	Imperial Chemical Industries Plc	Pharmazeutische Zubereitungen, die Spirosuccinimidderivate enthalten

1984
- 1984-09-17 AT AT84306332T patent/ATE30585T1/de not_active IP Right Cessation
- 1984-09-17 DE DE8484306332T patent/DE3467166D1/de not_active Expired
- 1984-09-17 EP EP84306332A patent/EP0136143B1/de not_active Expired
- 1984-09-20 GR GR80428A patent/GR80428B/el unknown
- 1984-09-21 JP JP59198395A patent/JPS6092264A/ja active Pending
- 1984-09-21 DK DK451184A patent/DK451184A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0136143B1 (de)	1987-11-04
DK451184D0 (da)	1984-09-21
JPS6092264A (ja)	1985-05-23
DK451184A (da)	1985-03-24
EP0136143A3 (en)	1985-05-15
EP0136143A2 (de)	1985-04-03
GR80428B (en)	1985-01-22
DE3467166D1 (en)	1987-12-10

Legal Events

Date	Code	Title	Description
1988-02-15	UEP	Publication of translation of european patent specification
1990-07-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
SE7906949L (sv)	1980-02-22	Nya spiro-oxazolidindioner
FI890311A0 (fi)	1989-01-20	Kemiska foereningar.
FR2415112A1 (fr)	1979-08-17	Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
MX24839A (es)	1993-10-01	3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE3854121D1 (de)	1995-08-10	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE30585T1 (de)	1987-11-15	Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.
DE69431199D1 (de)	2002-09-26	Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
DE69325141D1 (de)	1999-07-08	Behandlung von lignozellulosehaltigen Materialien
DE69432626D1 (de)	2003-06-12	Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
IE832854L (en)	1984-06-06	Spiro-3-hetero-azolones for treatment of diabetic¹complications.
ATE116850T1 (de)	1995-01-15	Mittel zur behandlung von erkrankungen der venen und des analbereichs.
DK316788A (da)	1988-12-13	Farmaceutisk praeparat og dets anvendelse
DE3778642D1 (de)	1992-06-04	Therapeutikum zur behandlung von magengeschwueren.
FI861125A0 (fi)	1986-03-18	Vid vaord av diabeteskomplikationer tillaempade spiroimidazoler.
DK149890C (da)	1987-04-21	Analogifremgangsmaade til fremstilling af n-(4-phenyl-2-thiazolyl)-oxamidsyre-2-ethoxyethylester
ATE127118T1 (de)	1995-09-15	2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.